Generated using OpenAI Deep Research API
The aatA gene of Penicillium chrysogenum encodes an enzyme acyl-coenzyme A:isopenicillin N acyltransferase (IAT), which catalyzes the final step of penicillin biosynthesis (pubmed.ncbi.nlm.nih.gov) (www.ncbi.nlm.nih.gov). This enzyme removes the hydrophilic L-α-aminoadipate side chain from isopenicillin N (IPN) and replaces it with a hydrophobic acyl group (e.g. phenylacetyl-CoA), converting IPN into penicillin (Penicillin G when phenylacetate is the side chain precursor) (www.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Biochemically, IAT exhibits acyltransferase activity: it can hydrolyze IPN to form the intermediate 6-aminopenicillanic acid (6-APA) and then acylate 6-APA with an activated acyl-CoA (pmc.ncbi.nlm.nih.gov). Notably, a single gene product is responsible for this two-step conversion, demonstrating that aatA (penDE) alone suffices to convert IPN to penicillin G (pmc.ncbi.nlm.nih.gov). The enzyme shows broad substrate flexibility in vitro, accepting various acyl-CoA donors (e.g. phenylacetyl-CoA for penicillin G, phenoxyacetyl-CoA for penicillin V) (bmcgenomics.biomedcentral.com).
Structurally, the IAT enzyme is initially synthesized as an ~40 kDa precursor polypeptide, which undergoes autocatalytic cleavage to yield a heterodimer of ~29 kDa and ~11 kDa subunits (pmc.ncbi.nlm.nih.gov). This self-processing generates a new N-terminal residue (Serine or Threonine) on the smaller subunit that acts as the catalytic nucleophile, classifying IAT as an N-terminal nucleophile (Ntn) hydrolase (pmc.ncbi.nlm.nih.gov). Indeed, P. chrysogenum IAT and its orthologs conserve a characteristic motif required for autocatalytic cleavage, indicating they belong to the Ntn-hydrolase family (pmc.ncbi.nlm.nih.gov). The active enzyme’s mechanism is akin to penicillin amidases: the nucleophilic N-terminal Ser hydrolyzes the amide bond of IPN (releasing free L-α-aminoadipate) and forms an acyl-enzyme intermediate, which is then resolved by transfer of a new acyl group to the penicillin nucleus (pmc.ncbi.nlm.nih.gov). The enzyme thereby exhibits multiple activities — isopenicillin N amidohydrolase, 6-APA acyltransferase, and penicillin amidase — all encoded by the single aatA/penDE gene product (pubmed.ncbi.nlm.nih.gov). Functionally, this step is essential for producing β-lactam antibiotics with different side chains and is rate-limiting under some conditions, as increasing IAT levels can boost penicillin yield (pubmed.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Importantly, the aatA-encoded IAT has no known homolog in bacteria (pubmed.ncbi.nlm.nih.gov), reflecting a unique evolutionary innovation in fungi for penicillin biosynthesis.
The AatA (IAT) enzyme is predominantly localized in peroxisomes (microbodies) within the fungal cell (pmc.ncbi.nlm.nih.gov) (www.ncbi.nlm.nih.gov). Immuno-electron microscopy and cell fractionation studies showed that the acyltransferase of penicillin biosynthesis resides in organelles ~200–800 nm in diameter, identified as microbodies (peroxisomes) in P. chrysogenum hyphae (pmc.ncbi.nlm.nih.gov). Consistently, the AatA protein carries a peroxisomal targeting signal type 1 (PTS1) at its C-terminus, which mediates its import into peroxisomes (pubmed.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). The PTS1 of P. chrysogenum IAT is an unusual but functional tripeptide sequence (e.g., “AKL” instead of the canonical “SKL”) that directs the enzyme to the peroxisomal matrix (www.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). The peroxisomal compartmentalization is biologically significant: peroxisomes host certain steps of penicillin biosynthesis, likely including activation of side-chain precursors (phenylacetyl-CoA formation via β-oxidation or ligation) and efficient enzymatic coupling (pmc.ncbi.nlm.nih.gov). In P. chrysogenum, mislocalization of IAT (for example, by removing its PTS1 or in peroxisome-deficient mutants) dramatically impairs penicillin production (www.ncbi.nlm.nih.gov) (www.ncbi.nlm.nih.gov), highlighting that correct peroxisomal targeting is critical for full enzymatic function in vivo. (This contrasts with Aspergillus nidulans, where a fraction of penicillin can still be made with cytosolic IAT (www.ncbi.nlm.nih.gov)). In summary, AatA is a peroxisomal matrix enzyme (GO:0005777) whose proper localization to microbodies is required for efficient antibiotic biosynthesis.
The aatA gene is a core component of the penicillin biosynthetic process (GO:0042318). Together with two upstream genes (pcbAB and pcbC), it forms part of the penicillin gene cluster responsible for the stepwise conversion of amino acids into β-lactam antibiotics (bmcgenomics.biomedcentral.com) (bmcgenomics.biomedcentral.com). Specifically, aatA participates in secondary metabolite biosynthesis, enabling the fungus to produce penicillin G (benzylpenicillin) when provided with phenylacetic acid, or penicillin V when provided with phenoxyacetic acid as the side-chain precursors (bmcgenomics.biomedcentral.com). Loss-of-function mutations or deletion of aatA (penDE) abolish penicillin production in P. chrysogenum, causing a “non-producing” phenotype (bmcgenomics.biomedcentral.com). For instance, P. chrysogenum mutants defective in penDE (historically named npe mutants) fail to convert isopenicillin N to penicillin, accumulating pathway intermediates and losing antibiotic synthesis capability (bmcgenomics.biomedcentral.com). Conversely, overexpression or multi-copy amplification of aatA elevates penicillin titers (pmc.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov), underscoring its involvement as a potential rate-limiting step in the β-lactam antibiotic biosynthetic pathway. Beyond antibiotic biosynthesis, aatA expression and activity indirectly influence cellular metabolism – for example, active penicillin production may drain precursors (like amino acids) and trigger compensatory upregulation of nitrogen metabolism genes (bmcgenomics.biomedcentral.com) (bmcgenomics.biomedcentral.com). However, aatA is not known to play roles outside secondary metabolism; it is highly specialized for penicillin/β-lactam antibiotic production. Consistent with this, homologs of aatA are found exclusively in penicillin-producing species and co-localize in the penicillin gene cluster (pubmed.ncbi.nlm.nih.gov), indicating that its biological role evolved specifically for antibiotic biosynthesis rather than primary cellular processes.
The AatA protein (isopenicillin N acyltransferase) is a bifunctional enzyme with distinct structural features supporting its activity. It belongs to the Ntn-hydrolase superfamily, characterized by an autocatalytic cleavage that generates a new N-terminal catalytic residue (pmc.ncbi.nlm.nih.gov). The translated polypeptide (~p40) contains an autoproteolytic cleavage site – a conserved motif (typically containing a Ser/Thr) – that is essential for self-processing into an α-subunit (~11 kDa) and a β-subunit (~29 kDa) (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This cleavage divides AatA into two domains: the small N-terminal domain (after cleavage, it becomes the active catalytic subunit with a free N-terminal Ser/Thr), and the larger C-terminal domain which completes the enzyme’s quaternary structure (pmc.ncbi.nlm.nih.gov). The N-terminal serine (or threonine) of the β-subunit serves as the catalytic nucleophile in the enzyme’s active site, analogous to bacterial penicillin acylases (pmc.ncbi.nlm.nih.gov). The protein’s tertiary structure has not been crystallized from P. chrysogenum, but by homology it is expected to form a barrel-like fold typical of penicillin acyltransferases, with the active site nestled at the interface of the subunits.
In terms of functional domains, AatA does not have multiple separately folded domains (it is a single-chain enzyme that cleaves into two parts, both of which remain associated). It contains sequence motifs common to β-lactam acyltransferases and amidases, including the conserved catalytic Ser-Lys dyad and oxyanion hole motif for acyl-transfer chemistry (e.g., a conserved glutamate or glycine-rich loop stabilizing transition state) (pubmed.ncbi.nlm.nih.gov). The extreme C-terminus contains a PTS1 tripeptide (such as SRL or AKL – single-letter amino acids) required for peroxisomal import (pubmed.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Notably, while AatA’s primary sequence has three introns (in P. chrysogenum and A. nidulans genes) (pmc.ncbi.nlm.nih.gov), the coding sequence encodes a polypeptide of ~357 amino acids (in P. chrysogenum penDE) that is functional after intron splicing and self-cleavage. No transmembrane segments or signal peptides are present, consistent with AatA being a soluble enzyme in the peroxisomal matrix. Instead, the enzyme’s key structural feature is its heterodimeric active form and the N-terminal nucleophile catalytic mechanism, distinguishing it from typical cytosolic transferases. These structural traits have been confirmed by sequence analysis and mutational studies: for example, site-directed mutations in the cleavage motif abolish activity by preventing proper subunit formation (pmc.ncbi.nlm.nih.gov). All known orthologs of AatA conserve this self-cleaving, heterodimer-forming architecture, indicating that these domains/features are crucial for function (pmc.ncbi.nlm.nih.gov).
Expression of the aatA gene is tightly regulated as part of the penicillin biosynthetic cluster. In P. chrysogenum, aatA (penDE) is co-regulated with the upstream pcbAB and pcbC genes, often from a shared bidirectional promoter region (www.ncbi.nlm.nih.gov). A 1.1-kb intergenic region controls divergent transcription of pcbC and penDE, allowing coordinated expression of the second and third pathway enzymes (www.ncbi.nlm.nih.gov). The cluster’s expression is subject to complex nutritional and developmental regulation (www.ncbi.nlm.nih.gov). For instance, carbon source affects aatA expression: high glucose represses transcription of penicillin biosynthesis genes (catabolite repression), independent of pH effects (www.ncbi.nlm.nih.gov). This likely involves the CreA/Cre1 glucose repression system, as penicillin production is favored in carbon-limited conditions. Nitrogen regulation also plays a role – promoter analysis identified GATA motifs, and nitrogen regulatory proteins (e.g. AreA in fungi) bind these sites (www.ncbi.nlm.nih.gov). Under nitrogen starvation or certain amino acid limitations, aatA expression is de-repressed, aligning with the concept that secondary metabolism (including antibiotic production) is activated when primary growth is limited (www.ncbi.nlm.nih.gov) (www.ncbi.nlm.nih.gov).
Moreover, specific inducers greatly elevate aatA expression. The presence of the side-chain precursor phenylacetic acid (PAA) is a well-known inducer of the penicillin gene cluster (bmcgenomics.biomedcentral.com). In cultivations of P. chrysogenum, adding PAA leads to increased transcription of pcbAB, pcbC, and penDE, correlating with penicillin G production (bmcgenomics.biomedcentral.com) (bmcgenomics.biomedcentral.com). The fungus senses PAA and upregulates the pathway to assimilate this precursor into the antibiotic. In contrast, in the absence of PAA (or presence of non-inducing conditions), aatA expression remains basal and penicillin production is minimal (bmcgenomics.biomedcentral.com). Experimentally, a P. chrysogenum strain where the entire penicillin cluster was deleted showed no induction by PAA and diverted metabolic capacity to other secondary metabolites (bmcgenomics.biomedcentral.com), indicating that aatA (along with pcbAB/C) is the primary PAA-responsive gene set.
Developmental and global regulators also impact aatA expression. P. chrysogenum and A. nidulans carry pathway-specific regulators; for example, a C6 zinc-cluster protein (encoded by pcbR or anaPc in some species) has been implicated in activating the penicillin cluster genes under appropriate conditions (www.ncbi.nlm.nih.gov) (www.ncbi.nlm.nih.gov). Additionally, global regulators of secondary metabolism such as LaeA (a methyltransferase influencing chromatin state) and the Velvet complex are known in Aspergilli to broadly control secondary metabolite gene clusters; deletion of laeA in P. chrysogenum leads to reduced penicillin gene expression and antibiotic titers (www.ncbi.nlm.nih.gov). The aatA promoter is also a target of general transcription factors: studies in A. nidulans identified two proteins, termed AnCF and AnBH1, that bind and regulate both aatA and its paralog aatB (pubmed.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). These factors appear to be conserved, likely corresponding to a CCAAT-binding complex (Hap complex) and another bZIP or Zn(II)2Cys6 regulator, respectively. In summary, aatA is tightly regulated by carbon and nitrogen catabolite repression, induced by precursor availability, and modulated by both cluster-specific and global regulatory proteins. Expression is upregulated in stationary phase or idiophase of fungal growth (when nutrients deplete and secondary metabolism kicks in), ensuring penicillin is produced in the later growth stages (www.ncbi.nlm.nih.gov).
As a gene from a filamentous fungus, P. chrysogenum aatA is not directly associated with human diseases. Penicillium chrysogenum (also known as P. rubens) is generally considered a saprophytic organism and is world-renowned for antibiotic production rather than pathogenicity. There are no known inherited or pathogenic “disease” mutations relevant to aatA, since it is not a human gene. In rare cases, P. chrysogenum can act as an opportunistic pathogen (causing, for example, necrotizing pneumonia or cutaneous infections in immunocompromised individuals) (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov), but aatA is not implicated in virulence or pathogenic processes in those instances. Instead, the “phenotypes” of interest for aatA are mainly industrial and biochemical. From a biotechnology perspective, aatA function is crucial for penicillin production, so its disruption yields a “non-producing” phenotype in fungal strains (bmcgenomics.biomedcentral.com). Classic studies identified mutant strains (e.g., npe mutants) where spontaneous mutations in penDE (aatA) led to loss of penicillin biosynthesis (pmc.ncbi.nlm.nih.gov). These mutants typically show normal growth of the fungus but accumulate isopenicillin N (or 6-APA) without secreting penicillin, confirming that aatA inactivation specifically knocks out antibiotic production (bmcgenomics.biomedcentral.com). Complementation of such mutants with a functional aatA gene restores penicillin synthesis (pmc.ncbi.nlm.nih.gov). Another phenotype is observed under peroxisomal dysfunction: P. chrysogenum strains defective in peroxisome biogenesis (or harboring a mutated PTS1 on IAT) have drastically lower penicillin yields, linking the aatA gene product’s localization to the antibiotic-producing phenotype (www.ncbi.nlm.nih.gov) (www.ncbi.nlm.nih.gov). In strain improvement programs, aatA is often amplified (multiple copies) along with other cluster genes; high-producing industrial strains of P. chrysogenum carry tandem repeats of the penicillin gene cluster, resulting in elevated aatA expression and increased penicillin output (bmcgenomics.biomedcentral.com) (bmcgenomics.biomedcentral.com). This gene dosage effect underscores aatA’s importance in the production phenotype. While aatA itself is not linked to human disease, its product – penicillin – is medically significant, and loss of aatA function would eliminate penicillin biosynthesis, thereby indirectly affecting the organism’s ecological interactions (e.g., reduced ability to inhibit competing microbes). There are no direct disease ontology terms for aatA, but experimentally the gene’s loss-of-function phenotype is “abolished antibiotic production,” and overexpression phenotype is “increased penicillin titer” (pmc.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov).
The aatA gene appears to be an evolutionary novelty confined to penicillin-producing fungi. Orthologs of P. chrysogenum aatA (often named penDE in Penicillia or aatA in Aspergillus nidulans) have been identified only in a small clade of ascomycetes that synthesize β-lactam antibiotics (pmc.ncbi.nlm.nih.gov). For example, A. nidulans possesses an aatA gene in its penicillin cluster that is functionally equivalent to penDE (pubmed.ncbi.nlm.nih.gov) (www.ncbi.nlm.nih.gov), and Aspergillus oryzae (which has the penicillin gene cluster) also carries a homolog (pmc.ncbi.nlm.nih.gov). Outside of these cases, no close bacterial or fungal homolog of aatA has been found in organisms that do not produce penicillins (pubmed.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This is consistent with penicillin biosynthesis being a specialized secondary metabolism – the genes were likely acquired or evolved in a common ancestor of Penicillium and certain Aspergillus species (pmc.ncbi.nlm.nih.gov). Interestingly, aatA homologs have three introns and a eukaryotic gene architecture, suggesting a eukaryotic origin (unlike the pcbAB gene, which is giant and might have bacterial origin) (pmc.ncbi.nlm.nih.gov). Evolutionary studies propose that penDE/aatA arose by gene duplication and divergence from a pre-existing ancestral enzyme in fungi (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). In A. nidulans, researchers discovered a paralogous gene named aatB (AN6775) that shares structure and partial function with aatA, though aatB lies outside the penicillin cluster (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). AatB is considered a non-cluster paralog present in some fungi (even those that don’t make penicillin), possibly representing the ancestral gene copy (pubmed.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). AatB lacks a peroxisomal targeting signal and encodes a cytosolic enzyme with low penicillin acyltransferase activity, yet it can partially compensate for aatA disruption when targeted to peroxisomes (pubmed.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). The presence of aatB in certain fungi (e.g., Aspergillus terreus, a non-penicillin producer (pmc.ncbi.nlm.nih.gov)) and the widespread distribution of distant “IAT-like” (ial) genes in many ascomycetes (pmc.ncbi.nlm.nih.gov) suggest that the penDE/aatA lineage was derived from a more ancient enzyme family. Phylogenetic analyses show that aatA (penDE) genes cluster tightly with each other (only penicillin-producers) while the ial genes form a separate clade of related Ntn-hydrolases found in various fungi (pmc.ncbi.nlm.nih.gov). These ial homologs have 0–2 introns and generally lack robust acyltransferase activity (pmc.ncbi.nlm.nih.gov), implying they serve a different physiological role. In summary, aatA is highly conserved within the penicillin-producing lineage but absent in most other organisms. Its evolution likely involved recruitment of a duplicated Ntn-hydrolase gene into the β-lactam gene cluster, acquisition of peroxisomal targeting (PTS1) for subcellular localization, and optimization for penicillin biosynthesis (pmc.ncbi.nlm.nih.gov). This makes aatA a notable example of a specialized, horizontally clustered enzyme in fungal secondary metabolism.
Relevant Gene Ontology (GO) Terms: Based on the above evidence, the aatA gene product can be annotated with GO terms such as “acyl-CoA:isopenicillin N N-acyltransferase activity” (GO:0102920, encompassing its EC 2.3.1.164 enzymatic function) (ctdbase.org), “penicillin biosynthetic process” (GO:0042318) (beta.glycosmos.org) for its role in antibiotic production, and “peroxisome” (GO:0005777) for its cellular component (www.ncbi.nlm.nih.gov). These annotations are supported by the literature: IAT’s catalytic activity has been demonstrated in vitro and in vivo (pmc.ncbi.nlm.nih.gov), its involvement in penicillin biosynthesis is genetically and biochemically proven (bmcgenomics.biomedcentral.com), and its peroxisomal localization is confirmed by microscopy and sequence signals (pmc.ncbi.nlm.nih.gov) (www.ncbi.nlm.nih.gov). The curated knowledge of aatA provides a foundation for understanding the molecular biology of β-lactam antibiotic production and for guiding metabolic engineering efforts to enhance penicillin yields.